Showing 17 companies
Cellino Biotech develops intracellular delivery lasers and nanotechnology for gene editing applications. The company makes stem cell differentiation a digital process, applying the latest tools from optics, biology, and computation to engineer functionally mature cells. Its technology enables the acceleration of the development time of engineered cells from years to weeks.
We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale. To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges.
Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes. Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.
Cell and gene therapies are at the forefront of innovation and have the potential to radically change healthcare with increased accessibility. Membio is on a mission to make the manufacturing of cell and gene therapies more cost effective. We’re doing this by developing a biomanufacturing platform that will enable the cost-effective and scalable production of whole cells for use in cell and gene therapies.
Mythic Therapeutics is a product-platform company that is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Our technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. At Mythic, we focus on patient-centered science and are driven to leave a lasting impact on cancer care.
There are 22M+ Americans who suffer from treatment-resistant mental health conditions, meaning they’ve failed two or more conventional treatments. Our mission is to further innovative mental treatments (ranging from FDA-approved psychedelic medicine to neuromodulation) for those who are suffering the most. We do this by empowering providers, improving patient care, and accelerating research. Our software is used by mental health doctors and their patients. We analyze multimodal data from the software to help the doctors deliver better care and also offer insights to help research and development of new treatments that actually work. Together, we can usher in the mental health revolution and help solve our world's mental health crisis. We are looking for mission-driven people passionate about solving our world's mental health crisis. We are a team of Stanford graduates (CS/Engineering, School of Medicine, Graduate School of Business) backed by Y Combinator and top-tier Silicon Valley VC’s.
Pair Team is on a mission to build the primary care infrastructure for America’s most vulnerable communities. They are the first tech-enabled care team that empowers safety-net primary care systems and the Medicaid & Medicare patients they serve. They act as an extension of the clinical staff to provide a personalized, high-touch care experience while addressing patients' barriers to care such as lack of transportation, housing/food insecurity, and mobile phone access. Internally, they are building a unique care delivery platform to ensure clinical best practices, integrate care with community-based organizations, and automate administrative work so that clinicians can focus on time with our patients.
Rarebase is a public benefit biotech led by scientists, engineers, patients and advocates. We leverage innovative technologies to build platforms that help us discover and develop treatments for the millions of people worldwide affected by the long tail of rare genetic disorders.